F Salvati

761 total citations
23 papers, 575 citations indexed

About

F Salvati is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, F Salvati has authored 23 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in F Salvati's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (5 papers) and Occupational and environmental lung diseases (3 papers). F Salvati is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (5 papers) and Occupational and environmental lung diseases (3 papers). F Salvati collaborates with scholars based in Italy, Germany and India. F Salvati's co-authors include Giorgio V. Scagliotti, Maurizio Tonato, F. Figoli, Luigi Dogliotti, M. Marangolo, Filippo de Marinis, Pasquale Incoronato, Giorgio Cruciani, M. Clerici and Lucio Crinò and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Cancer.

In The Last Decade

F Salvati

21 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Salvati Italy 10 378 293 114 76 33 23 575
C. Stoffregen Germany 15 246 0.7× 264 0.9× 201 1.8× 181 2.4× 17 0.5× 41 678
Eric Himmelfarb United States 10 161 0.4× 146 0.5× 160 1.4× 132 1.7× 21 0.6× 14 458
Marcello Ferretti Fanelli Brazil 16 305 0.8× 410 1.4× 119 1.0× 80 1.1× 24 0.7× 47 697
Karakousis Cp United States 16 154 0.4× 391 1.3× 158 1.4× 129 1.7× 69 2.1× 37 565
Manabu Yamamoto Japan 11 253 0.7× 237 0.8× 160 1.4× 117 1.5× 15 0.5× 26 556
J-L. Pujol France 9 465 1.2× 414 1.4× 117 1.0× 66 0.9× 46 1.4× 15 658
Titia E. Lans Netherlands 14 185 0.5× 246 0.8× 94 0.8× 140 1.8× 85 2.6× 29 491
Henry A. Briele United States 13 258 0.7× 412 1.4× 121 1.1× 115 1.5× 50 1.5× 18 580
Paul Monk United States 11 167 0.4× 228 0.8× 104 0.9× 82 1.1× 52 1.6× 50 390
I. Garassino Italy 13 342 0.9× 271 0.9× 92 0.8× 106 1.4× 6 0.2× 28 547

Countries citing papers authored by F Salvati

Since Specialization
Citations

This map shows the geographic impact of F Salvati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Salvati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Salvati more than expected).

Fields of papers citing papers by F Salvati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Salvati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Salvati. The network helps show where F Salvati may publish in the future.

Co-authorship network of co-authors of F Salvati

This figure shows the co-authorship network connecting the top 25 collaborators of F Salvati. A scholar is included among the top collaborators of F Salvati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Salvati. F Salvati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perrone, Emanuele, Ilaria Capasso, Matteo Loverro, et al.. (2025). Lymphovascular Space Invasion In Endometrial Cancer Molecular Era: A Large, Retrospective, Tertiary Center Analysis.. International Journal of Gynecological Cancer. 35(2). 100251–100251. 1 indexed citations
2.
Franciosini, Gaia, G. Battistoni, Augusto Cerqua, et al.. (2022). GPU-accelerated Monte Carlo simulation of electron and photon interactions for radiotherapy applications. Physics in Medicine and Biology. 68(4). 44001–44001. 11 indexed citations
3.
Salvati, F, et al.. (2008). Mucoid metaplastic-degeneration of anterior cruciate ligament.. PubMed. 48(4). 483–7. 40 indexed citations
4.
Perrone, Fabiana, et al.. (2004). Cost of non-small cell lung cancer in Italy. Results of the longitudinal study ALCEA (Advanced Lung Cancer Economic Assessment). Journal of Clinical Oncology. 22(14_suppl). 8265–8265. 3 indexed citations
5.
Crinò, Lucio, Giorgio V. Scagliotti, M. Marangolo, et al.. (1997). Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.. Journal of Clinical Oncology. 15(1). 297–303. 268 indexed citations
6.
Salvati, F, et al.. (1996). Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial.. PubMed. 16(2). 1001–4. 38 indexed citations
7.
Crinò, Lucio, M. Marangolo, F. Figoli, et al.. (1995). 1064 Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study. European Journal of Cancer. 31. S222–S222. 12 indexed citations
8.
Baldini, Editta, Andrea Ardizzoni, M.C. Pennucci, et al.. (1995). 1059 Cisplatin, Vindesine, Mitomycin (MVP) vs Cisplatin, Ifosfamide, Navelbine (PIN) vs Carboplatin, Navelbine (CAN) in advanced non-small cell lung cancer (NSCLC). European Journal of Cancer. 31. S221–S222. 1 indexed citations
9.
Ardizzoni, Andrea, M.C. Pennucci, B. Castagneto, et al.. (1994). Recombinant Interferon Alpha-2b in the Treatment of Diffuse Malignant Pleural Mesothelioma. American Journal of Clinical Oncology. 17(1). 80–82. 29 indexed citations
10.
Teodori, Laura, et al.. (1992). Cellular heterogeneity of DNA/total‐protein content in human lung tumors, as determined by flow cytometry. International Journal of Cancer. 50(6). 845–853. 8 indexed citations
11.
Ardizzoni, Andrea, R. Rosso, F Salvati, et al.. (1991). Combination Chemotherapy and Interferon α2b in the Treatment of Advanced Non-Small-Cell Lung Cancer. American Journal of Clinical Oncology. 14(2). 120–123. 11 indexed citations
12.
13.
Benedetti, E., et al.. (1989). Micro FT-IR Characterization Of Human Lung Tumor Cells. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 1145. 515–515. 1 indexed citations
14.
Rosso, R., F Salvati, M. De Palma, et al.. (1988). Intrapleural Natural Beta Interferon in the Treatment of Malignant Pleural Effusions. Oncology. 45(3). 253–256. 59 indexed citations
15.
Salvati, F, et al.. (1985). Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage.. PubMed. 8(1-2). 111–4. 14 indexed citations
16.
Salvati, F, et al.. (1985). [Multiple neoplastic combinations in the aged. Case contribution].. PubMed. 76(17-18). 859–64. 1 indexed citations
17.
Riario-Sforza, G, et al.. (1982). [The Pelger-Huet granulocytic anomaly: first report of 2 homozygous subjects in the same family].. PubMed. 138(4). 511–5. 2 indexed citations
18.
Salvati, F, et al.. (1981). [Pelger-Hüet's congenital anomaly: morphologic and functional study on 140 cases in Abruzzo (author's transl)].. PubMed. 66(1). 46–56. 2 indexed citations
19.
Salvati, F, et al.. (1979). [The Pelger-Huet granulocytic anomaly].. PubMed. 70(14). 977–80. 1 indexed citations
20.
Salvati, F, et al.. (1963). [RARE ENCEPHALIC LOCALIZATION OF HODGKIN'S LYMPHOGRANULOMA].. PubMed. 24. 457–75. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Stoffregen Breakdown of academic impact, for papers by Eric Himmelfarb Breakdown of academic impact, for papers by Marcello Ferretti Fanelli Breakdown of academic impact, for papers by Karakousis Cp Breakdown of academic impact, for papers by Manabu Yamamoto Breakdown of academic impact, for papers by J-L. Pujol Breakdown of academic impact, for papers by Titia E. Lans Breakdown of academic impact, for papers by Henry A. Briele Breakdown of academic impact, for papers by Paul Monk Breakdown of academic impact, for papers by I. Garassino
Rankless by CCL
2026